» Articles » PMID: 32455975

A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 May 28
PMID 32455975
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in adults in developed countries. CVD encompasses many diseased states, including hypertension, coronary artery disease and atherosclerosis. Studies in animal models and human studies have elucidated the contribution of many genetic factors, including non-coding RNAs. Non-coding RNAs are RNAs not translated into protein, involved in gene expression regulation post-transcriptionally and implicated in CVD. Of these, circular RNAs (circRNAs) and microRNAs are relevant. CircRNAs are created by the back-splicing of pre-messenger RNA and have been underexplored as contributors to CVD. These circRNAs may also act as biomarkers of human disease, as they can be extracted from whole blood, plasma, saliva and seminal fluid. CircRNAs have recently been implicated in various disease processes, including hypertension and other cardiovascular disease. This review article will explore the promising and emerging roles of circRNAs as potential biomarkers and therapeutic targets in CVD, in particular hypertension.

Citing Articles

Research trends and hotspots of circular RNA in cardiovascular disease: A bibliometric analysis.

Xu Z, Guan C, Cheng Z, Zhou H, Qin W, Feng J Noncoding RNA Res. 2024; 9(3):930-944.

PMID: 38680417 PMC: 11047193. DOI: 10.1016/j.ncrna.2024.04.002.


Alleviation of Angiotensin II-Induced Vascular Endothelial Cell Injury Through Long Non-coding RNA TUG1 Inhibition.

Shi L, Li H, Sun L, Tian C, Li H Comb Chem High Throughput Screen. 2023; 27(10):1523-1532.

PMID: 37818575 DOI: 10.2174/0113862073265220231004071645.


Genome-wide screening for circRNAs in epicardial adipose tissue of heart failure patients with preserved ejection fraction.

He S, Zhu H, Zhang J, Yang X, Zhao L Am J Transl Res. 2023; 15(7):4610-4619.

PMID: 37560213 PMC: 10408519.


Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases.

Singh D, Kim Y, Choi S, Han I, Yadav D Cells. 2023; 12(12).

PMID: 37371099 PMC: 10297435. DOI: 10.3390/cells12121629.


CircHIPK2 facilitates phenotypic switching of vascular smooth muscle cells in hypertension.

Liu C, Li N, Li F, Deng W, Dai G, Tang Y J Hum Hypertens. 2023; 37(11):1021-1027.

PMID: 37100987 DOI: 10.1038/s41371-023-00834-w.


References
1.
Kontaraki J, Marketou M, Zacharis E, Parthenakis F, Vardas P . Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension. J Hum Hypertens. 2013; 28(8):510-6. DOI: 10.1038/jhh.2013.117. View

2.
Zhu X, Yuan Y, Rao S, Wang P . LncRNA MIAT enhances cardiac hypertrophy partly through sponging miR-150. Eur Rev Med Pharmacol Sci. 2016; 20(17):3653-60. View

3.
Holdt L, Stahringer A, Sass K, Pichler G, Kulak N, Wilfert W . Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans. Nat Commun. 2016; 7:12429. PMC: 4992165. DOI: 10.1038/ncomms12429. View

4.
Lei W, Feng T, Fang X, Yu Y, Yang J, Zhao Z . Signature of circular RNAs in human induced pluripotent stem cells and derived cardiomyocytes. Stem Cell Res Ther. 2018; 9(1):56. PMC: 5845222. DOI: 10.1186/s13287-018-0793-5. View

5.
Yang L, Yang F, Zhao H, Wang M, Zhang Y . Circular RNA circCHFR Facilitates the Proliferation and Migration of Vascular Smooth Muscle via miR-370/FOXO1/Cyclin D1 Pathway. Mol Ther Nucleic Acids. 2019; 16:434-441. PMC: 6488807. DOI: 10.1016/j.omtn.2019.02.028. View